USANA Health Sciences, Inc. (USNA) is a Utah-based developer and manufacturer of science-based nutritional supplements, functional foods, and personal care and skincare products. The company operates through its Core Nutritional direct-selling business, the Hiya children's health brand, and Rise Wellness, and has been transitioning toward a diversified omnichannel model spanning direct-to-consumer, subscription, and retail channels.
Shares of USNA were modestly higher in early trading on November 11, 2026, rising about 0.46%, or $0.06, to $13.16, compared with a prior closing price of $13.10. The gain confirmed an upward move for the session, though it was a comparatively quiet one, suggesting investors were stepping cautiously after the prior day's sharp decline.
The most immediate context for today's move is the previous session's selloff. On November 10, USNA shares fell 5.42% to $13.10, extending the weakness that has followed the company's third-quarter earnings report. Today's fractional advance therefore reads as a tentative stabilization rather than a fresh, catalyst-driven rally.
With no major corporate announcement or analyst action driving the tape, the modest gain appears tied to light bargain hunting and short-term traders buying the dip after the stock's recent slide. Such muted, post-decline bounces are common when sentiment is still absorbing negative fundamental news and no new information has emerged to change the narrative.
Underpinning the cautious tone is the company's fiscal third-quarter report, released after the market close on November 3, 2026. USNA posted net sales of about $206 million, down 4% year over year and below analyst expectations, while adjusted diluted EPS of negative $0.11 also missed estimates. Core Nutritional active customers declined 8% year over year, with weakness concentrated in the Greater China market, the company's largest region.
The results were not uniformly negative. Hiya's active monthly subscribers grew 18% sequentially, adding roughly 29,500 net subscribers, and the Southeast Asia Pacific region returned to year-over-year net sales growth. Management also raised Hiya's full-year net sales outlook to $130 million. However, the company lowered its consolidated full-year outlook, now expecting net sales approaching $900 million and adjusted EBITDA of approximately $77 million, reflecting softer results at Rise Wellness and increased investment at Hiya.
These mixed signals have left the market without a clear directional catalyst, contributing to the stock's recent volatility and today's muted price action.
Trading in USNA remained relatively quiet during the early session, consistent with a stock that is consolidating after a period of elevated volatility. The prior session's decline occurred on above-average volume, and today's modest gain has not yet been accompanied by the kind of conviction that would suggest a durable reversal.
The stock continues to trade well below its 52-week high, reflecting a prolonged downtrend in the small-cap health and wellness space. Without a pronounced move in broader indices or a notable shift in the consumer staples and direct-selling sectors, USNA has largely traded on its own fundamental story in recent sessions.
Looking ahead, investors will be focused on whether the company can stabilize its Core Nutritional active-customer base while sustaining the subscriber momentum at Hiya. Management has signaled that its planned incentive-plan refinements and 2027 product introductions are aimed at improving customer acquisition and loyalty, but the benefits are expected to build gradually.
Key risks include ongoing softness in Greater China, the lumpy and unpredictable nature of Rise Wellness club-channel sales, and margin pressure from increased marketing investment at Hiya. On the positive side, the company ended the quarter with $179 million in cash and no debt, which provides financial flexibility to fund its omnichannel transformation. The next quarterly earnings report and updates on full-year guidance will be the primary catalysts for determining whether the stock can sustain any recovery.
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that are delivering the strongest performance under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, each varying by strategy, timeframe, performance metrics, and the symbols they trade. Only the most robust performers are featured in this section, helping traders and investors identify data-driven approaches that align with today's market environment. Explore the Trending AI Robots to see which strategies are currently standing out.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
USNA moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend. In 26 of 34 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 76%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on USNA as a result. In 63 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for USNA turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 35 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
The 10-day moving average for USNA crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 65 cases where USNA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
Following a +3.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where USNA advanced for three days, in 162 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
USNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 96 of 158 cases where USNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.478) is normal, around the industry mean (6.914). P/E Ratio (-11.551) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.698) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.296) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. USNA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Develops and manufactures nutritional, personal care and weight-management products
Industry FoodMajorDiversified